Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

References

• Haskard D. O. Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 2004; 33: 281–92
   PubMed Web of Science ®Google Scholar
• van Doornum S., McColl G., Wicks I. P. Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis?. Arthritis Rheum 2002; 46: 862–73
   PubMed Web of Science ®Google Scholar
• Criqui M. H., Golomb B. A. Epidemiologic aspects of lipids abnormalities. Am J Med 1998; 105: 48S–57S
   PubMedGoogle Scholar
• Rantapaa‐Dahlqvist S., Wallberg Jonsson S., Dahlen G. Lipoprotein(a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991; 50: 36–8
   PubMed Web of Science ®Google Scholar
• Boers M., Nurmohamed M. T., Doelman C. J. A., Lard L. R., Verhoeven A. C., Voskuyl A. E., et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62: 842–5
   PubMed Web of Science ®Google Scholar
• Wallberg‐Jonsson S., Uddhammar A., Dahlen G., Rantapaa‐Dahlqvist S. Lipoprotein(a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica. Scand J Clin Lab Invest 1995; 55: 309–15
   PubMed Web of Science ®Google Scholar
• McDevitt H., Munson S., Ettinger R., Wu A. Multiple roles for tumor necrosis factor‐α and lymphotoxin α/β in immunity and autoimmunity. Arthritis Res 2002; 4((Suppl 3))141–52
   Google Scholar
• Hansson G. K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–95
   PubMed Web of Science ®Google Scholar
• Branen L., Hovgaard L., Nitulescu M., Bengtsson E., Nilsson J., Jovinge S. Inhibition of tumor necrosis factor‐alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004; 24: 2137–42
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Prevoo M. L. L., van't Hof M. A., Kuper H. H., van Rijswijk M. H., van de Putte L. B. A., van Riel P. L. C. M. Modified disease activity scores that include twenty‐eight‐joint counts. Arthritis Rheum 1995; 38: 44–8
   PubMed Web of Science ®Google Scholar
• Cauza E., Cauza K., Hanusch‐Enserer U., Etemad M., Dunky A., Kostner K. Intravenous anti TNF‐alpha antibody therapy leads to elevated triglyceride and reduced HDL‐cholesterol levels in patients with rheumatoid and psoriatic arthritis. Wien Klin Wochenschr 2002; 114: 1004–7
   PubMed Web of Science ®Google Scholar
• Popa C., Netea M. G., Radstake T., Van der Meer J. W., Stalenhoef A. F., van Riel P. L., et al. Influence of anti‐tumor necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2005; 64: 303–5
   PubMed Web of Science ®Google Scholar
• Vis M., Nurmohamed M. T., Wolbink G., Voskuyl A. E., de Koning M., van de Stadt R., et al. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 252–5
   PubMed Web of Science ®Google Scholar
• Park Y. ‐B., Choi H. K., Kim M. ‐Y., Lee W. ‐K., Song J., Kim D. ‐K., et al. Effects of anti‐rheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002; 113: 188–93
   PubMed Web of Science ®Google Scholar
• Rohrer L., Hersberger M., von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 2004; 15: 269–78
   PubMed Web of Science ®Google Scholar
• Jacobsson L. T., Turesson C., Gulfe A., Kapetanovic M. C., Petersson I. F., Saxne T., et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1213–18
   PubMed Web of Science ®Google Scholar
• Sethi J. K., Hotamisligil G. S. The role of TNF in adipocyte metabolism. Cell Dev Biol 1999; 10: 19–29
   Google Scholar
• Ofei F., Hurel S., Newkirk J., Sopwith M., Taylor R. Effects of an engineered human anti‐TNF‐alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996; 45: 881–5
   PubMed Web of Science ®Google Scholar